SCHEMBL129789

SCHEMBL129789

COc1c(CO)ccc2cc3[n+](cc12)CCc1c-3cc(-c2ccc(-c3ccccc3)cc2)c2c1OCO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 2/20 0.47
ACHE P22303 7/20 0.46
BCHE P06276 6/20 0.46
PREP P48147 4/20 0.46
ALDH1A1 P00352 3/20 0.45
LMNA P02545 3/20 0.45
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MEN1 O00255 2/20 0.45
KDM1A O60341 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 2/20 0.45
CHRM1 P11229 2/20 0.45
DRD2 P14416 2/20 0.45
TSHR P16473 2/20 0.45
ADRA2B P18089 2/20 0.45
ADRA2C P18825 2/20 0.45
RXRA P19793 2/20 0.45
DRD1 P21728 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL129785 0.81 ACHE (0.43) CYP1B1ACHEBCHEPREPALDH1A1
SCHEMBL129791 0.79 ACHE (0.41) CYP1B1ACHEBCHEPREPALDH1A1
SCHEMBL127656 0.77 ACHE (0.38) CYP1B1ACHEBCHEPREPALDH1A1
SCHEMBL128821 0.76 CYP3A4 (0.39) CYP1B1ACHEBCHEPREPALDH1A1
SCHEMBL12641839 0.76 CYP1B1 (0.78) CYP1B1ACHEBCHEPREPALDH1A1
SCHEMBL14477482 0.72 CYP3A4 (0.76) CYP1B1ACHEBCHEALDH1A1LMNA
SCHEMBL18472033 0.72 RAC1 (0.74) CYP1B1ACHEBCHEALDH1A1LMNA
SCHEMBL127654 0.71 P2RX7 (0.42) ACHEBCHEPREPALDH1A1LMNA
SCHEMBL129768 0.71 PTGS1 (0.44) CYP1B1ACHEBCHEPREPALDH1A1
SCHEMBL18472034 0.70 ACHE (0.79) CYP1B1ACHEBCHEALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9227966-B2 Antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-01-05 US disclosed
US-20140315939-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-10-23 US disclosed
US-20120059026-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059026-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L CYP1B1 531/4885ACHE 3213/4885BCHE 2274/4885
US-20140315939-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L CYP1B1 715/4885ACHE 3734/4885BCHE 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.